PDCD1 and neoplasm: Many tumours exhibit few T cells and a high number of immunosuppressive cells, including myeloid-derived suppressor cells, tumour-associated macrophages, and regulatory T cells, which exhibit immune-cold characteristics and lead to resistance to anti-PD1 therapy [162, 163].